Cytokinetics, IncorporatedCYTKNASDAQ
Loading
Year-over-year SG&A expense growth
| Period | Value |
|---|---|
| Q4 2025 | 32.06% |
| Q3 2025 | 5.69% |
| Q2 2025 | 14.56% |
| Q1 2025 | -7.97% |
| Q4 2024 | 10.04% |
| Q3 2024 | 11.47% |
| Q2 2024 | 11.70% |
| Q1 2024 | 3.14% |
| Q4 2023 | 9.98% |
| Q3 2023 | 0.98% |
| Q2 2023 | -20.02% |
| Q1 2023 | -7.97% |
| Q4 2022 | 11.92% |
| Q3 2022 | 12.89% |
| Q2 2022 | 29.17% |
| Q1 2022 | -2.18% |
| Q4 2021 | 29.02% |
| Q3 2021 | 23.61% |
| Q2 2021 | 35.90% |
| Q1 2021 | 12.15% |
| Q4 2020 | 13.05% |
| Q3 2020 | -13.13% |
| Q2 2020 | 13.75% |
| Q1 2020 | 17.62% |
| Q4 2019 | 8.52% |
| Q3 2019 | -0.84% |
| Q2 2019 | 4.23% |
| Q1 2019 | 24.86% |
| Q4 2018 | 5.50% |
| Q3 2018 | -10.96% |
| Q2 2018 | -13.15% |
| Q1 2018 | -9.70% |
| Q4 2017 | 6.23% |
| Q3 2017 | 14.45% |
| Q2 2017 | 3.98% |
| Q1 2017 | 21.57% |
| Q4 2016 | -7.51% |
| Q3 2016 | 1.79% |
| Q2 2016 | 3.64% |
| Q1 2016 | 23.73% |